According to a 2016 ISR survey, 80% of respondents stated that Phase I studies are becoming more complex and 90% plan to increase the number of sites for early stage trials. To compete, sponsors continually search for opportunities to contain costs while addressing increasingly unique study needs and pressure to shorten timelines.
In this webinar, you’ll explore how to simplify and streamline Phase I and IIa study execution through clinical technology, including:
- Implementing a cost-effective, pre-configured and pre-packaged solution for early phase trials
- Making a rapid transition from early stage to Phase IIb / III, where needs scale to include more sites, larger patient pools and more complex study designs